Claims
- 1. A method for removing amino terminal dipeptides from a precursor polypeptide to produce a polypeptide product, which precursor polypeptide comprises an even number of amino acids extended from a peptide bond which is to be, after removal of said dipeptides, an amino terminus of said polypeptide product, said method comprising contacting said precursor polypeptide with an approximately 225 kilodalton dipeptidylaminopeptildase (dDAP) which is isolated from Dictyosteliurn discoideum and has a pH optimum of approximately 3.5, under conditions sufficient to allow the action of said dDAP to sequentially remove amino-terminal dipeptides from said precursor polypeptide to produce the polypeptide product.
- 2. A method for removing an amino-terminal dipeptide from a precursor polypeptide to produce a polypeptide product, which precursor polypeptide comprises a dipeptide extended from a peptide bond which is to be, after removal of said dipeptides, an amino terminus of said polypeptide product, said method comprising contacting said precursor polypeptide with an approximately 225 kilodalton dipeptidylaminopeptidase (dDAP) which is isolated from Dictyostelium discoideum and has a pH optimum of approximately 3.5, under conditions sufficient to allow the action of said dDAP to remove the amino-terminal dipeptide from said precursor polypeptide to produce the polypeptide product.
- 3. The method of claim 2 wherein the precursor polypeptide is selected from the group consisting of a precursor of human proinsulin, a precursor of human growth hormone, and a precursor of an analog of human proinsulin.
- 4. The method of claim 3 wherein said precursor polypeptide is a precursor of human proinsulin.
- 5. The method of claim 3 wherein said precursor polypeptide is a precursor of human growth hormone.
- 6. The method of claim 3 wherein said precursor polypeptide is a precursor of an analog of human proinsulin.
- 7. The method of claim 4 wherein the precursor of human proinsulin is Met-Tyr-Proinsulin.
- 8. The method of claim 4 wherein the precursor of human proinsulin is Met-Arg-Proinsulin.
- 9. The method of claim 5 wherein the precursor of human growth hormone is Met-Asp-Human Growth Hormone.
- 10. The method of claim 6 wherein the precursor of an analog of human proinsulin is [Lys.sup.B28, Pro.sup.B29 ]-Met-Arg-Proinsulin.
- 11. The method of claim 6 wherein the precursor of an analog of human proinsulin is [Lys.sup.B28, Pro.sup.B29 ]-Met-Tyr-Proinsulin.
- 12. The method of claim 6 wherein the precursor of an analog of human proinsulin is [Asp.sup.B10, des B28-B30]-Met- Arg- Proinsulin.
- 13. The method of claim 6 wherein the precursor of an analog of human proinsulin is [Asp.sup.B10, des B28-B30]-Met-Tyr-Proinsulin.
- 14. The method of claim 2 wherein said precursor polypeptide is contacted with said dDAP between about 1 minute and about 24 hours.
- 15. The method of claim 14 wherein said precursor polypeptide is contacted with said dDAP between about 1 and about 8 hours.
- 16. The method of claim 16 wherein said precursor polypeptide is contacted with said dDAP in a solution of between about pH 2.5 and about pH 5.5.
- 17. The method of claim 16 wherein said precursor polypeptide is contacted with said dDAP in a solution of between about pH 3.0 and about pH 4.5.
- 18. The method of claim 17 wherein said precursor polypeptide is contacted with said dDAP in a solution of between about pH 3.5.
- 19. The method of claim 2 wherein said precursor polypeptide is contacted with said dDAP at temperature of between about 15.degree. C. and about 45.degree. C.
- 20. The method of claim 19 wherein said precursor polypeptide is contacted with said dDAP at temperature of between about 20.degree. C. and about 37.degree. C.
- 21. The method of claim 20 wherein said precursor polypeptide is contacted with said dDAP at temperature of between about 25.degree. C. and about 37.degree. C.
- 22. The method of claim 2 wherein the N-terminal amino acid of said dipeptide is an oxidized methionine.
Parent Case Info
This application is a division, of application Ser. No. 08/301,519, filed Sep. 7, 1994, now allowed, which is a continuation of application Ser. No. 07/955,539, filed Oct. 1, 1992, now abandoned.
US Referenced Citations (11)
Foreign Referenced Citations (2)
Number |
Date |
Country |
0397420 |
Apr 1990 |
EPX |
0217814 |
May 1990 |
EPX |
Non-Patent Literature Citations (3)
Entry |
Chan, et. al., 1985, Biochem. Biophys. Res. Comm., 127(3): 962-968. |
Chan, et. al., 1987, Experimental Mycology, 11: 27-35. |
Huang, et. al., 1992, Experimental Mycology, 16: 102-109. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
301519 |
Sep 1994 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
955539 |
Oct 1992 |
|